000 02419 a2200697 4500
005 20250518030658.0
264 0 _c20200602
008 202006s 0 0 eng d
022 _a2468-1253
024 7 _a10.1016/S2468-1253(19)30077-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNaimi, Rahim M
245 0 0 _aGlepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial.
_h[electronic resource]
260 _bThe lancet. Gastroenterology & hepatology
_c05 2019
300 _a354-363 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAbdominal Pain
_xchemically induced
650 0 4 _aAged
650 0 4 _aAnorexia
_xchemically induced
650 0 4 _aColitis, Ulcerative
_xsurgery
650 0 4 _aCrohn Disease
_xsurgery
650 0 4 _aCross-Over Studies
650 0 4 _aDouble-Blind Method
650 0 4 _aEdema
_xchemically induced
650 0 4 _aEnterostomy
650 0 4 _aFatigue
_xchemically induced
650 0 4 _aFemale
650 0 4 _aGastrointestinal Agents
_xtherapeutic use
650 0 4 _aGastrointestinal Transit
650 0 4 _aGlucagon-Like Peptide 2
650 0 4 _aHumans
650 0 4 _aInjection Site Reaction
650 0 4 _aIntestinal Absorption
650 0 4 _aMale
650 0 4 _aMesenteric Ischemia
_xsurgery
650 0 4 _aMesenteric Vascular Occlusion
_xsurgery
650 0 4 _aMiddle Aged
650 0 4 _aNausea
_xchemically induced
650 0 4 _aShort Bowel Syndrome
_xdrug therapy
700 1 _aHvistendahl, Mark
700 1 _aEnevoldsen, Lotte H
700 1 _aMadsen, Jan L
700 1 _aFuglsang, Stefan
700 1 _aPoulsen, Steen S
700 1 _aKissow, Hannelouise
700 1 _aPedersen, Jens
700 1 _aNerup, Nikolaj
700 1 _aAmbrus, Rikard
700 1 _aAchiam, Michael P
700 1 _aSvendsen, Lars B
700 1 _aHolst, Jens J
700 1 _aHartmann, Bolette
700 1 _aHansen, Svend H
700 1 _aDragsted, Lars O
700 1 _aSteensberg, Adam
700 1 _aMouritzen, Ulrik
700 1 _aHansen, Mark B
700 1 _aJeppesen, Palle B
773 0 _tThe lancet. Gastroenterology & hepatology
_gvol. 4
_gno. 5
_gp. 354-363
856 4 0 _uhttps://doi.org/10.1016/S2468-1253(19)30077-9
_zAvailable from publisher's website
999 _c29486058
_d29486058